Healthcare - Biotechnology - NASDAQ - US
$ 17.85
-6.25 %
$ 668 M
Market Cap
12.4
P/E
Price Target
Average
6.44%
Revenue Forecast
Estimate
23.98%
EBIT
Estimate
197.79%
Net Income
Estimate
--120.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Entrada Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TRDA of $19 , with forecasts ranging from a low of $18 to a high of $20 .
TRDA Lowest Price Target
Wall Street Target
18 USD
0.84%
TRDA Average Price Target
Wall Street Target
19 USD
6.44%
TRDA Highest Price Target
Wall Street Target
20 USD
12.04%
REVENUE FORECAST
Revenue Forecast Chart TRDA
EBIT FORECAST
EBIT Forecast Chart TRDA
NET INCOME FORECAST
Net Income Chart TRDA